CT-derived body composition measurements as predictors for neoadjuvant treatment tolerance and survival in gastroesophageal adenocarcinoma.
Mariana R DeFreitasAmadu ToronkaMarybeth A NedrudSarah CubberleyIslam H ZakiBrandon KonkelHope E UronisManisha PaltaDan G BlazerKyle J LafataMustafa R BashirPublished in: Abdominal radiology (New York) (2022)
CT-based measures of body composition in patients with gastroesophageal adenocarcinoma may be independent predictors of treatment complications and survival and can supplement methods for assessing functional status during treatment planning.